Victrex (LON:VCT) Stock Price Crosses Above Two Hundred Day Moving Average – Time to Sell?

Posted by Bonnie Powley on Jan 20th, 2026

Shares of Victrex plc (LON:VCT – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 677.45 and traded as high as GBX 705. Victrex shares last traded at GBX 695, with a volume of 230,248 shares.

Analyst Upgrades and Downgrades

Separately, Deutsche Bank Aktiengesellschaft decreased their price target on shares of Victrex from GBX 850 to GBX 780 and set a “hold” rating on the stock in a report on Tuesday, December 2nd. Four equities research analysts have rated the stock with a Hold rating, According to MarketBeat, Victrex has a consensus rating of “Hold” and an average target price of GBX 804.50.

Check Out Our Latest Analysis on Victrex

Victrex Stock Down 0.7%

The company has a debt-to-equity ratio of 10.93, a current ratio of 4.39 and a quick ratio of 1.99. The stock has a market capitalization of £605.14 million, a P/E ratio of 21.86, a P/E/G ratio of 1.92 and a beta of 0.69. The firm has a 50-day simple moving average of GBX 648.91 and a 200 day simple moving average of GBX 677.45.

Victrex (LON:VCT – Get Free Report) last released its quarterly earnings results on Tuesday, December 2nd. The company reported GBX 43.90 earnings per share for the quarter. Victrex had a return on equity of 6.67% and a net margin of 10.81%. On average, equities research analysts forecast that Victrex plc will post 73.1078905 EPS for the current year.

Insider Transactions at Victrex

In other Victrex news, insider Ian Melling purchased 3,500 shares of the company’s stock in a transaction dated Wednesday, December 17th. The stock was purchased at an average price of GBX 643 per share, with a total value of £22,505. Company insiders own 4.10% of the company’s stock.

Victrex Company Profile

(Get Free Report)

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.